BioPharma Today
BioPharma Today is a FREE website published by Elsevier Business Intelligence.
- To register for our daily email, click here.
- To join our LinkedIn group, click here.
- To follow us on Twitter, click here.
Elsevier Business Intelligence
Elsevier Business Intelligence is the leading source for biopharma and medical device regulatory, reimbursement and business intelligence. With the largest, most experienced team of analysts in the industry, EBI is connected to a comprehensive network of decision makers in industry and government – including U.S. FDA, the European Medicines Agency and China’s SFDA – who provide critical intelligence you won’t find elsewhere. Find out why regulators and top life sciences executives in the U.S., Europe and Asia trust EBI publications like “The Pink Sheet”, IN VIVO and PharmAsia News to deliver what you need to know, and why you need to know it – subscribe today.
Where biopharma industry professionals turn for business, regulatory and reimbursement intelligence
Elsevier Business Intelligence places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Built on the proud heritage of F-D-C Reports, Windhover Information and Medtech Insight, Elsevier Business Intelligence is a leader in the field of healthcare industry information.
Trust the largest team of news analysts dedicated exclusively to your industry
Our highly experienced and respected news analysts provide you with insider business, regulatory and reimbursement intelligence on the biopharma, medical device, non-prescription drug, nutritionals, and cosmetics industries.
Our biopharma publications:
- "The Pink Sheet"- Biopharma business, regulatory and reimbursement intelligence from the largest, most experienced team of news analysts in the industry. Want more? Download a complimentary issue of "The Pink Sheet" - Click here .
- "The Pink Sheet" DAILY- Daily, in-depth analysis of the key developments shaping the biopharma industry. Sign up for a free trial today! Click here.
- PharmAsia News - Biopharma and medical device business, regulatory and reimbursement intelligence from news analysts based in China, India, Japan, Korea, Australia and the Pacific Rim. Sign up for a free trial today! Click here.
- "The Gold Sheet" - The most insightful analysis to help you comply with biopharma manufacturing QA/QC requirements in the U.S. and internationally. Download a complimentary issue today! Click here.
- "Pharmaceutical Approvals Monthly" - REMs requirements, user fee goals, Advisory committee action, FDA approval decisions, trial results,– it’s all in "Pharmaceutical Approvals Monthly". Download a complimentary issue today! Click here
- IN VIVO - The premier strategic business resource for the biopharma, medtech, and diagnostics industries. For subscription information, or to register for a free sample, click here.
- Start-Up -No publication reviews leading edge companies and technology better than START-UP. Each issue of START-UP profiles the most important new product companies, identifies the hottest technology areas, reviews funds flowing into private companies and investment trends, and reports on university tech transfer licensing. Request a sample issue of Start-Up Today! Click here.
- The RPM Report -The RPM Report delivers easy-to-understand, practical insight on how regulatory and policy developments at FDA impact your business. Request a sample issue of The RPM Report Today! Click here.
Find out why Today's "Pink Sheet" is the world's most widely-read resource for biopharma business, regulatory and reimbursement intelligence.
